Many reagents have been emerged to study the function of specific enzymes in 17 vitro. On the other hand, target specific reagents are scarce or need improvement allowing 18 investigations of the function of individual enzymes in a cellular context. We here report the 19 development of a target-selective fluorescent small-molecule activity-based DUB probe that is 20 active in live cells and whole animals. The probe labels active Ubiquitin Carboxy-terminal 21
INTRODUCTION
Selectivity for UCHL1 was further confirmed by IC50 determination against a panel of other 23 cysteine DUBs (including USP7, USP30 and USP16) and the non-DUB cysteine protease 24 papain, showing over 50-fold difference in IC50 value ( Figure 1C and Supporting Information 25 Table S1 ). We next performed a jump dilution experiment 29 in which 100 final assay 26 concentration of UCHL1 was treated with 10 µM of 6RK73 followed by 100 times dilution 27 into substrate-containing buffer and direct fluorescence read-out ( Figure 1C , D). Only after 30 28 minutes a negligible increase in fluorescence signal could be detected which indicates that the 29 inhibitor acts basically irreversible. The formation of a stable covalent complex between 30 UCHL1 and a single 6RK73 molecule was confirmed in an experiment where UCHL1 was 31 incubated with 6RK73 and the reaction followed by LC-MS analysis (see Supporting   32 Information). Next, we investigated whether the compound would inhibit UCHL1 in live cells. HEK293T cells were treated with 5 µM 6RK73 or the commercially available active-site 1 directed reversible UCHL1 inhibitor LDN-57444 30 for 24h, followed by cell lysis and treatment 2 with the fluorescent broad-spectrum DUB probe Rhodamine-Ubiquitin-propargylamide (Rh-3 Ub-PA) to label all residual cysteine-DUB activity. 31, 32 The samples were denatured, resolved 4 by SDS-PAGE and scanned for Rhodamine fluorescence ( Figure 1E ). Each band represents an 5 active DUB that reacted with the probe and the ability of a compound to inhibit a DUB is 6 reflected by disappearance of its corresponding band. Indeed, the band belonging to UCHL1 33 7 disappears upon treatment with 6RK73, whereas all other bands remain unchanged, indicating 8 that 6RK73 selectively inhibits UCHL1 in the presence of other DUBs in cells. In comparison, 9 UCHL1 is hardly inhibited by LDN-57444 in this experiment, despite their comparable IC50 From inhibitor to probe. 14 Given the high inhibitory potency and UCHL1 selectivity both in vitro and in cells and the fact 15 that it forms an irreversible covalent bond we envisioned that this type of cyanimide-containing 16 molecules can serve as an ideal starting point for the construction of small-molecule selective 17 DUB ABPs. This would require the instalment of a reporter group (e.g. fluorescent label) onto 18 the molecule. Upon close inspection of 6RK73 however, we realized that this molecule does 19 not provide an appropriate site for modification. We therefore generated azide 8RK64 to which 20 then several reporter groups were coupled using the copper(I)-catalyzed azide alkyne 21 cycloaddition (CuAAC) or 'click reaction'. The compounds and their synthesis routes are 22 shown in Scheme 1. Compound 2 was synthesized from 4-piperidinone (1) in four steps 23 according to a reported procedure. 26 The Fmoc-protected piperidine amine was liberated with 24 DBU and coupled to 2-azidoacetic acid resulting in compound 3. Next, the Boc protecting 25 group was removed from the pyrrolidine amine, followed by a reaction with cyanogen bromide 26 to install the cyanimide moiety resulting in 8RK64. Treatment of UCHL1 with this compound 27 followed by IC50 determination and LC-MS analysis gave results comparable to those for 28 6RK73 (Figure 2A , B, Supporting Information), which indicates that 8RK64 also functions as 29 a UCHL1 covalent inhibitor. With an IC50 value of 0.32 µM towards UCHL1 and 216 µM and 30 >1 mM towards UCHL3 and UCHL5 respectively (Figure 2A , Supporting Information Table   31 S1), this compound also retained its UCHL1 selectivity. In addition, 8RK64, like 6RK73, also 32 inhibits UCHL1 activity in cells as shown in a DUB profiling experiment in HEK293T cells 33 5 using a Cy5-Ub-PA probe ( Figure 2C ). Notably, 8RK64 could potentially be used as '2-step 1 ABP' by taking advantage of its azide moiety. 34 2 3 Installation of a dye preserves inhibitory properties. 4 As it was unclear what the effect of coupling a bulky fluorescent group would have on the 5 UCHL1 inhibition profiles and cell permeability we decided to test three commonly used 6 fluorophores. BodipyFL-alkyne, BodipyTMR-alkyne 35 and Rhodamine110-alkyne (for 7 preparation see Supporting Information) were coupled using copper(I)-mediated click 8 chemistry to the azide of 8RK64, resulting in compounds 8RK59, 9RK15 and 9RK87 9 (Scheme 1). These 'one-step' ABPs can potentially be used for visualization of UCHL1 activity 10 without the need for additional bio-orthogonal chemistry procedures. IC50 determination of 11 these probes against UCHL1 revealed that the instalment of the dyes affected the inhibitory 12 potency only marginally ( Figure 3A and Supporting Information Table S1 ). Rhodamine110 13 probe 9RK87 is almost as potent as its azide precursor 8RK64 with IC50 values of 0.44 µM 14 and 0.32 µM respectively. Instalment of BodipyTMR (9RK15) on the other hand, resulted in 15 a 10-fold potency decrease, although the data points could not be fitted properly to a dose-16 response function. The less bulky BodipyFL-ABP 8RK59, although not as potent as 8RK64, 17 showed a very acceptable inhibition of UCHL1 with an IC50 close to 1 µM. The ability of 18 8RK59 to form a covalent complex with UCHL1 was confirmed in an LC-MS experiment as 19 described above (Supporting Information).
21
ABPs can visualize UCHL1 activity and the covalent linkage is thermally reversed. 22 We next set out to investigate whether the probes can be used to label and visualize UCHL1 23 activity after SDS-PAGE and fluorescence gel scanning similar to the Rh-Ub-PA probe. To 24 our surprise for none of the three small-molecule probes a clear band corresponding to probe-25 labelled UCHL1 could be detected after incubation with purified recombinant human UCHL1. 26 We reasoned that the isothiourea bond between UCHL1 and probe, which is stable under the 27 conditions used for inhibition and LC-MS experiments (vide supra), might be susceptible to 28 the conditions used for protein denaturation, e.g. boiling in the presence of ~300 mM β-29 mercaptoethanol. Indeed, when the same samples were resolved by SDS-PAGE under non-30 denaturing conditions (no boiling and absence of β-mercaptoethanol) a clear band appeared 31 that corresponds to probe-labelled UCHL1 for all three probes ( Figure 3B ). We also 32 investigated if the ABP-UCHL1 bond would survive when β-mercaptoethanol is replaced by 33 tris(2-carboxyethyl)phosphine) (TCEP), both of which are used to create a reducing 34 6 environment. Figure 3B clearly shows that the ABP-UCHL1 bands remain intact in the 1 presence of 50 mM TCEP and show a better-resolved profile (less smearing) compared to the 2 non-reducing samples. The Rh-Ub-PA control samples show that nearly all UCHL1 is labeled 3 and that the formed bond for this probe is stable under denaturing conditions, which 4 corroborates earlier findings. 31 The bands corresponding to Rh-Ub-PA and 9RK87 bound to 5 UCHL1 (both bearing the same dye and present in equal amounts) are of similar intensity, 6 which indicates that the small-molecule probes bind UCHL1 efficiently and that all UCHL1 is 7 active upon probe engagement. ABPs bind to the active site cysteine residue of UCHL1 and visualize UCHL1 activity in 10 various cell lines. 11 We next assessed the ability of the probes to bind and inhibit UCHL1 in a cell lysate by treating 12 HEK293T cell extracts with 5 µM of the three fluorescent probes, as well as their azide 13 precursor 8RK64 and inhibitor 6RK73 for 1 hour followed by labelling of all residual DUB 14 activity with Cy5-Ub-PA. The Cy5-labelled Ub probe was used here to circumvent spectral 15 interference with either of the other dyes used in the small-molecule probes. Fluorescent 16 scanning of the gel after SDS-PAGE as well as Western blotting using anti-UCHL1 antibody 17 clearly showed that Rhodamine probe 9RK87 inhibits UCHL1 activity similar to 8RK64 and 18 6RK73 ( Figure 3C ). Both Bodipy probes also potently inhibit UCHL1 in a cell lysate, although 19 to a somewhat lesser extent, which could be expected on the basis of their IC50 values. All other 20 bands are unchanged, which demonstrates that all compounds are able to bind UCHL1 21 selectively with respect to other DUBs in a cell lysate.
22
Encouraged by these results we set out to assess the ability of the probes to penetrate the cell 23 membrane and to label active UCHL1 in cells. HEK293T cells were treated with 5 µM of the 24 probes for 24 hours followed by cell lysis, SDS-PAGE (in the absence of β-mercaptoethanol 25 and boiling) and fluorescence scanning at two wavelengths to detect all fluorescent dyes 26 ( Figure 3D ). A clear band just above 25 kDa is observed for both Bodipy probes (8RK59 and 27 9RK15), which likely corresponds to ABP-labelled UCHL1 with an expected mass of ~25.5 28 kDa. In addition to this band a few extra bands are visible including one just below UCHL1 29 and one more pronounced band around 55 kDa. Interestingly, hardly any band can be seen for 30 the so-far most potent probe 9RK87. We attributed this effect to the difference in cell 31 permeability between Bodipy and Rhodamine dyes, with the latter known to be less capable of 32 crossing the cell membrane. 36 Indeed, upon further investigation using microscopy in ABP-33 treated HeLa and HEK293T cells we confirmed that Rhodamine probe 9RK87 is unable to 34 7 enter these cells, whereas both Bodipy ABPs clearly are (Supporting Information Figure S1 ).
1
For this reason and because the BodipyFL-ABP proved to be a better inhibitor compared to its 2 BodipyTMR analogue we decided to continue with 8RK59 as the preferred probe for all further 3 experiments.
4
The ability of 8RK59 to label UCHL1 activity in different cell lines was further explored in 5 HEK293T cells and in three cancer cell lines known to express high levels of endogenous Flag-HA-tagged UCHL1 and its C90A catalytic inactive mutant in HEK293T cells and 16 incubated these cells with 5 µM 8RK59 for 24 hours. Fluorescence scanning and anti-FLAG 17 Western blotting shows that 8RK59 only binds to wild-type UCHL1 but not to catalytically 18 inactive UCHL1, indicating that the probe binding site is the active site cysteine ( Figure 3F ).
20
Determination of DUB selectivity and potential off-targets of the ABP. 21 As mentioned before, besides the band corresponding to ABP-labelled UCHL1 a few other 22 bands appeared on gel ( Figure 3D ) but based on the DUB profiling results ( Figure 3C ) these 23 bands can most likely not be attributed to other DUBs. In order to gain more insight into 24 potential off-targets we performed pull-down experiments coupled to mass spectrometry to 25 identify the proteins binding to our probe. We started with a '2-step ABP' approach in which 26 HEK293T cells were incubated with azide-containing compound 8RK64 or DMSO control, 27 followed by a post-lysis click reaction with biotin-alkyne 38 and subsequent pull-down with 28 neutravidin-coated beads (Supporting Information Figure S2A , B). Samples were run (1 cm) 29 on a SDS-PAGE gel, lanes were cut into two pieces and the proteins were subjected to trypsin 30 digestion and analyzed by LC-MSMS. As expected, the most enriched protein identified from 31 this experiment was UCHL1 (Supporting Information Figure S2C ). Only one additional protein 32 was also highly enriched, a protein deglycase named DJ-1 (PARK7) with a molecular weight 33 of 20 kDa, which most likely corresponds to the band just below UCHL1 in Figure 3D . This 34 8 enzyme also harbors an active site cysteine residue which could potentially bind to our probe.
1 Indeed, incubation of UCHL1 and PARK7 knock-down cells with 8RK59, followed by anti-2 UCHL1 and anti-PARK7 Western blotting, revealed that PARK7 also reacts with 8RK59 and 3 that the gel band just below UCHL1 corresponds to PARK7 (Supporting Information Figure   4 S2D).
5
In addition to UCHL1 and PARK7, a few other bands can be seen on gel, yet we only identified 6 these two enzymes in the 2-step ABP approach. We therefore performed a 1-step pull-down 7 experiment where we used two biotinylated versions of 8RK64: compound 11RK72 where 8 biotin is directly linked to the inhibitor and compound 11RK73 with a PEG spacer in between.
9
Both compounds show high inhibitory potential towards UCHL1 ( Figure 4A ) and form a 10 covalent bond with UCHL1 (Supporting Information). HEK293T cell lysate was incubated 11 with both biotin-ABPs, followed by pull-down with neutravidin-coated beads and subjected to 12 full proteome LC-MSMS analysis ( Figure 4B , Supporting Information Figure S2E ). Efficient 13 UCHL1 pull-down was confirmed for both biotinylated probes but not the DMSO and biotin-14 alkyne-treated control samples by Western blotting using anti-UCHL1 antibody ( Figure 4C ).
15
From the LC-MSMS data, the relative protein abundances were calculated in the pull-down substantiates the specificity of the probes for UCHL1 within the Ub system as shown in Figure   20 4D. Only a few of these enzymes were identified in the pull-down experiment with at least 21 150-fold lower abundance compared to UCHL1. The first other DUB on the list is UCHL3, the 22 closest UCHL1 family member, and one of the most abundant DUBs in cells, which could 23 explain this result.
24
The abundances of the top-10 highest ranked proteins are shown in Figure 4E . In line with the 25 results obtained with the 2-step approach, the highest ranked proteins are UCHL1 and PARK7.
26
PARK7 shows a slightly higher abundance here, which contradicts our previous results from 27 the in-cell labeling and 2-step pull-down experiments and might be attributed to the use of a 28 different (biotinylated) version of the ABP or a peptide ionization difference during LC-MSMS 29 measurements. The next highest ranked group of proteins, albeit at much lower abundance 30 levels, includes two amidases NIT1 and NIT2, both harboring an active-site cysteine residue, 31 the isochorismatase domain-containing protein 2 (ISOC2) and glutamine amidotransferase-like 32 class-1 domain-containing protein 3B (GATD3B). Overall, the shorter (11RK72) and longer 33 9 (11RK73) biotin probes give similar results, so the distance between probe and biotin does not 1 seem to influence the binding nor the pull-down efficiency. 3) we were unable to assign all bands to proteins. The majority of most abundant proteins in 4 the pull-down experiment have a molecular weight between 20 and 35 kDa. Especially the 5 pronounced band around 55 kDa in Figure 3D remains elusive. In a final attempt to assign this 6 band we resolved the pull-down protein sample from the 1-step labeling experiment by SDS-7 PAGE. All proteins were visualized by silver staining after which the bands were excised and 8 analyzed by LC-MSMS (Supporting Information Figure S2F ). Again, UCHL1 and PARK7 9 were clearly the main proteins identified from the bands at ~25 kDa. The proteins 10 corresponding to the other bands were less clear but the main candidates were GAPDH at ~40 11 kDa and Elongation factor 1α, tubulin or glutathione reductase (GSR) at ~60 kDa. Whether or 12 not these proteins actually bind to the probe or that these results are due to their high expression 13 levels remains elusive. Based on the result that we identified UCHL1 as the major probe target 14 in three individual experiments and that we found PARK7 as the only major off-target, we 15 reasoned that 8RK59 could well be used for in-cell and in vivo labelling of UCHL1 activity. Figure S3 ). After imaging, MDA-MB-436 cells were lysed and followed with SDS-PAGE, 24 fluorescence gel scanning and immunoblotting. A decreased UCHL1 signal was detected in 25 MDA-MB-436 UCHL1 knock-down cells by 8RK59 and by antibody stain ( Figure 5B ). To 26 further validate whether we can visualize UCHL1 specific activity inside cells, control and 27 UCHL1 depleted A549 cells were pre-incubated with 8RK59 probe for 16 hours and stained 28 with UCHL1 antibody ( Figure 5C ). We observed changes in the distribution of the probe inside 29 the cells. In the control cells 8RK59 accumulated in both UCHL1-positive and negative 30 subcellular compartments while in the UCHL1 knock-down cells the 8RK59 signal was largely 31 decreased in the UCHL1-positive compartments, implying that UCHL1 binds to 8RK59 probe.
32
In agreement with the gel-based labeling data shown in Figure 3 Probing UCHL1 activity in zebrafish embryos with 8RK59. 6 To investigate the application of 8RK59 in tracking UCHL1 activity in an in vivo model, we 7 chose the zebrafish (Danio rerio) due to their high genetic homology to humans and the 8 transparency of their embryos. 39 Firstly, we treated zebrafish embryos with 8RK59 and 9 recorded fluorescent images during the development of embryos from 1 to 7 days post 10 fertilization (dpf). Results showed 8RK59 mainly labeled the nose, eye and brain of the 11 zebrafish embryos ( Figure 6A ). Interestingly, all these organs are enriched in nerve cells and 12 highly express Uchl1 mRNA. 40 To validate that the labelling of 8RK59 in zebrafish embryos 13 is specific to UCHL1 protein, we fixed the 8RK59 labelled embryos and performed IF staining 14 with UCHL1 antibody. Results demonstrated both the 8RK59 and UCHL1 antibody label 15 similar organs of zebrafish embryos ( Figure 6B ). To assess whether 8RK59 could detect the 16 UCHL1 activity changes in zebrafish embryos, we pretreated the zebrafish embryos with 17 UCHL1 activity inhibitor 6RK73 from 1 to 3 dpf, and then labelled the embryos with 8RK59 18 from 4 to 6 dpf. We found that increasing concentrations of 6RK73-pretreated zebrafish 19 embryos resulted in significantly lower 8RK59 signal labelling ( Figure 6C ). In addition, the 20 lysate of 6RK73-pretreated zebrafish embryos showed decreased UCHL1 signal in 21 fluorescence scans of a corresponding SDS-PAGE gel (Supporting Information Figure S4 ).
22
These in vivo experiments indicate that 8RK59 can visualize and track UCHL1 activity during 23 the development of zebrafish embryos. One of the key challenges within DUB research is the creation of activity-based probes that 27 target a single DUB type and at the same time are able to cross the cell membrane, in order to 28 study these enzymes inside living cells or even living organisms. 41 It has recently been shown 29 by us and others that Ub-based tools (such as ABPs) can be made sub-type specific by 30 engineering the amino acid sequence in Ub, 32, 4243 however these ABPs are not cell-permeable, 31 although the use of cell-penetrating peptides has recently been applied to deliver Ub ABPs into 32 cells. 44 ABPs based on small-molecule inhibitors on the other hand are often cell-permeable 33 and can be tuned chemically to become selective, 45, 46 although such ABPs for DUBs have been 34 lacking so far. We here provide evidence for the first fluorescent small-molecule target specific 1 DUB ABP (8RK59) that hits UCHL1 activity in vitro, in cells and in vivo. We based our design probes Rhodamine-tagged 9RK87 showed better in vitro characteristics, e.g. lower IC50 value 12 and more potent in cell lysate, but unfortunately proved to be unable to cross the cell membrane.
13
As such, this probe could be preferred for in vitro experiments and might be optimized for in- is not different for our compounds. We have considerably invested in the identification of 17 potential off-targets of our probes by means of a proteomics approach. The data generated in 18 this effort are not only useful for our own study but also provide valuable information for others 19 working on this type of cyanimide-containing compounds. The proteomics data is in line with 20 the Ub-probe experiments, confirming that these compounds are UCHL1 specific within the 21 Ub system and to enzymes of the closely related Ub-like systems (e.g. Nedd8, SUMO, etc.).
22
We indeed found a few potential off-targets, the main one being the protein and nucleotide 23 deglycase PARK7. These cyanimide compounds may therefore provide a good starting point 24 for small-molecule probes targeting PARK7, which, in spite of its important enzymatic 25 function in protein and DNA repair in virtually any cell, have not been developed yet. Based 26 on our data we expect that the potency and selectivity of the probe can be further improved by 27 means of chemical alterations of the inhibitor. A better knowledge on the structural 28 determinants of the interactions between probe and UCHL1 will be of great value for this, 29 unfortunately despite several crystallization attempts we were unable to obtain appropriately 30 diffracting crystals. During preparation of our manuscript Flaherty and co-workers 47 reported 31 on a related (S)-1-cyanopyrrolidine-2-carboxamide-based UCHL1 inhibitor and they applied 32 NMR and molecular modeling to gain insight in the interactions between inhibitor and UCHL1, 33 which could provide useful information to further optimize our probes. In addition, they 34 modified their inhibitor with an alkyne moiety, which, unlike our molecules, resulted in a 1 decrease in potency towards UCHL1 and selectivity with respect to UCHL3. This 2-step probe 2 was then used to identify off-targets in KMS11 cells but remarkably none of their identified 3 proteins show overlap with our list.
4
In conclusion, we have developed a fluorescent small-molecule activity-based probe that labels 5 UCHL1 activity in vitro, in cells and in vivo. It is the first example of a '1-step' DUB-selective, 6 cell-permeable ABP and therefore serves as a unique addition to the 'Ub toolbox', 7 concomitantly addressing two of the outstanding challenges within this field. Our results show 8 that the probe works in several different cell lines and we therefore foresee a potential wide 9 application of the probe in studying UCHL1 activity related to neurodegenerative disorders 10 and cancer. In fact, we recently showed that 6RK73 decreases UCHL1 activity and thereby 11 inhibits TGFβ/SMAD2 and SMAD3 signaling and breast cancer migration and extravasation. 48
12
We are convinced that the here reported strategy of small-molecule cyanimide-based probes 13 can be expanded to other cysteine proteases and specifically DUBs. With the rising importance 14 of the Ub system as source of practical drug targets we believe that these ABP tools will fill an For siRNA transfection, siRNAs targeting UCHL1 (Set of 4: siGENOME; MQ-004309-00-13 0002 2 nmol) and PARK7 (Set of 4: siGENOME; MQ-005984-00-0002 2 nmol) were obtained shaking for 20 min. at room temperature. The transfection mix was added to cells and cultured 18 at 37 °C and 5 % CO2. 48 hours after transfection 8RK59 was added to the cells and incubated 19 for 24 hours. Cells were harvested and analysed as described under the section "DUB activity 20 profiling and competition with Ub-PA DUB probes".
21
For the expression of UCHL1 in HEK293T cells, Flag-HA-UCHL1 construct was obtained 22 from Addgene (22563). Catalytically inactive mutant (C90A) UCHL1 was generated using 23 site-directed mutagenesis. Wild-type and C90A mutant UCHL1 were transfected into 24 HEK293T cells using PEI transfection reagent. 24 hours after transfection 8RK59 was added 25 to the cells and incubated for 24 hours. Cells were harvested and analysed as described under 26 the section "DUB activity profiling and competition with Ub-PA DUB probes".
28
Immunoblotting. Cells were lysed in HR lysis buffer (50 mM Tris, 5 mM MgCl2, 250 mM 29 sucrose and 2 mM DTT, pH 7.4) with protease inhibitor cocktail for 10 min. on ice. The lysates 30 were sonicated using 10 cycles of 30 sec. pulse on, 30 sec. pulse off. The lysates were 31 centrifuged at maximun speed for 20 min. at 4 °C, thereafter protein concentrations were 32 measured using the DC protein assay (500-0111; Bio-Rad) and equal amounts of proteins were 33 16 used for each condition that was analyzed by immunoblotting with following antibodies: 1 UCHL1 (ab27053; Abcam), Tubulin (2148; Cell Signaling), GAPDH (MAB374; Millipore), 2 Actin (A5441; Sigma-Aldrich,).
3 4 Immunofluorescence staining. Cells were fixed for 20 min. in 4% paraformaldehyde and then 5 permeabilized in 0.1% Triton-X for 10 min. Non-specific binding was blocked with blocking 6 buffer (1% BSA in 0.1% PBS-Tween) for 30 min. The primary antibody UCHL1 (ab27053; 7 Abcam) was diluted in blocking buffer and added to the cell for 1 hour. After 3 times washing 8 with PBS, the secondary antibody donkey anti rabbit IgG Alexa Fluorescence 555 (Invitrogen 9 #A31572) was added and incubated for 30 min. After 3 times washing with PBS, samples were 10 mounted with VECTASHIELD antifade mounting medium with DAPI (H-1200; Vector 11 Laboratories). Fluorescence images were acquired with TCS SP8 confocal microscope (Leica).
12
Zebrafish embryos were fixed with 4% paraformaldehyde 2 hours at room temperature.
13
Samples were dehydrated with 33%, 66%, 100% methanol in PBS, followed by a rehydration 14 step. Thereafter, the embryos were successively treated with 10 μg/mL proteinase K for 60 15 min. at 37 °C, permeabilized with 0.25% Triton in PBS for 30 min. on ice, and blocked with 16 10% FBS in PBS for 1 hour at room temperature. Embryos were incubated with primary 17 antibody (ab27053; Abcam) for at least 12 hours at 4 °C. After washing with 0.1% Triton in 18 PBS for 3 times 10 min., the samples were incubated with fluorescein-conjugated secondary 19 antibody donkey anti rabbit IgG Alexa Fluorescence 555 (Invitrogen #A31572) for 2 hours at 20 room temperature. After washing with PBS (0.1% Triton), samples were analyzed using a 21 confocal microscope SP5 STED (Leica, Rijswijk, Netherlands). shRNAs, siRNAs or UCHL1 constructs as described above. 5 µM final concentration of probes 5 were added to the cell a day before harvesting. Cells were harvested in HR buffer as described 6 above. NuPAGE LDS sample buffer containing 50 mM TCEP was added to cell lysates. Beads were washed six times in wash buffer containing 50 mM HEPES pH 7.3, 150 mM NaCl 21 and 1% NP-40. After completely removing the washing buffer, NuPAGE LDS sample buffer 22 (containing 7.5% β-mercaptoethanol) was added to the beads followed by 15 min. incubation 23 at 95 °C.
24
For 2-step approach, 4  10 6 HEK293T cells were seeded into 10 cm dishes for each treatment. was 120,000, the scan range 400-1500, at an AGC target of 400,000 @maximum fill time of 20 50 ms. Dynamic exclusion after n=1 with exclusion duration of 10 s. Charge states 2-5 were 21 included. For MS2 precursors were isolated with the quadrupole with an isolation width of 1.2 22 Da. HCD collision energy was set to 32V. First mass was set to 110 Da. The MS2 scan 23 resolution was 30,000 with an AGC target of 50,000 @maximum fill time of 60 ms.
In a post-analysis process, raw data were first converted to peak lists using Proteome was performed with a Leica SP5 STED confocal microscope (Leica, Rijswijk, Netherlands).
5
The quantification of 8RK59 signal was analyzed by Leica microscope software platform LAS 6 X. 30 zebrafish were treated in each group and 3 representative images were taken and 7 analyzed. Statistical analysis was performed using Graphpad Prism 8 software. Numerical data 8 from triplicates are presented as the mean ± SD. Two-way analysis of variance (ANOVA) has 9 been used to analyze multiple subjects. 3)
